INDIAN Drug Manufacturers Association (IDMA), the largest body of small and mid-sized pharma companies, has taken up some concerns of the pharmaceutical industry with the government. The matters include issues such as Chinese competition for the Active Pharmaceutical Ingredients (API) market, pharma pricing and foreign direct investment (FDI) in the sector.
展开▼
